Invention Grant
- Patent Title: Monoclonal antibodies that react with the capsule of Bacillus anthracis
- Patent Title (中): 与炭疽杆菌胶囊反应的单克隆抗体
-
Application No.: US13935956Application Date: 2013-07-05
-
Publication No.: US09273124B2Publication Date: 2016-03-01
- Inventor: Zhaochun Chen , Robert H. Purcell , Rachel Schneerson , Joanna Kubler-Kielb , Lily Z. Dai
- Applicant: The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Applicant Address: US DC Washington
- Assignee: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services
- Current Assignee: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services
- Current Assignee Address: US DC Washington
- Agency: Klarquist Sparkman, LLP
- Main IPC: A61K39/07
- IPC: A61K39/07 ; C07K16/12 ; G01N33/569 ; A61K39/395 ; A61K39/40 ; A61K39/00

Abstract:
The present disclosure relates to monoclonal antibodies that bind poly-γ-D-glutamic acid (γDPGA), which is present on the surface of Bacillus anthracis. The disclosure also provides chimeric forms of the monoclonal antibodies, humanized forms of the monoclonal antibodies, and fragments thereof, as well as nucleic acids encoding the antibodies and fragments thereof. Pharmaceutical compositions including such antibodies are also disclosed herein. The disclosure further provides prophylactic, therapeutic, and diagnostic methods of using the disclosed antibodies.
Public/Granted literature
- US20130287787A1 MONOCLONAL ANTIBODIES THAT REACT WITH THE CAPSULE OF BACILLUS ANTHRACIS Public/Granted day:2013-10-31
Information query